Pharma News

Nearly a year after Coherus BioSciences' Udenyca syringes were rejected due to external manufacturing issues, a third-party manufacturer is once again troubling the California-based pharmaceutical company.

The news is significant because Novo Nordisk CEO Lars Jorgensen is scheduled to appear next week before the Senate Health, Education, Labor and Pensions Committee (HELP), which Sanders chairs.

On Tuesday, Daiichi Sankyo (4568.T) and Merck & Co (MRK.N) announced that its drug patritumab deruxtecan achieved its main goal in a clinical trial in advanced patients, extending the period of disease-free progression in some lung cancer patients.

A senior executive at Danish pharmaceutical giant Novo Nordisk revealed that the company expects its diabetes drug Ozempic to be "highly likely" to be included in the U.S. government's list for drug price negotiations in 2027.

Abbvie had filed an infringement lawsuit against Beigene in June last year, claiming that it infringed ibrutinib's patent rights.

An industrial chemical used in plastic products has popped up in illegal drugs from California to Maine, a sudden and inexplicable shift in drug supply that has health researchers on alert.

On September 13, Li Li, director of the State Medical Products Administration, made clear his support for open cooperation in the pharmaceutical industry at a high-profile press conference.

Eli Lilly and Company announced it will invest $1.8 billion in two manufacturing sites in Ireland to boost production of its drugs for treating obesity and Alzheimer's disease.

Pharmaceutical companies are investing up to $1 trillion in new biotech innovations.

This article mainly introduces the application of medical talcum powder in the preparation process and its application as a pharmaceutical excipient.

• Medical talcum powder

British pharmaceutical giant GlaxoSmithKline (GSK) has achieved encouraging mid-stage trial results for the seasonal flu vaccine program it is developing, the company announced in a statement released Thursday.

The original product of tomoxetine hydrochloride, a drug used to treat ADHD, has been discontinued in the Chinese market due to market competition.

The COVID-19 outbreak has highlighted the importance of vaccines. The pandemic has killed 16 million people, adding a harrowing statistic to the global death toll.

The maker of diabetes treatments Wegovy and Ozempic reported in March that its oral insulin mimics reduced body weight by 13.1 percent over 12 weeks in a phase I trial, sending its shares up more than 8 percent.

Astrazeneca confirmed in a statement late Thursday that some of its employees were under investigation by Chinese police, but gave no further information.

The U.S. House of Representatives on Monday passed a bill aimed at restricting business with China's Wuxi Apptec (603259.SS), BGI (BGI) and several other biotech companies on national security grounds.

The results certainly disappointed investors and analysts who had been closely watching the late-stage trial and had high hopes that the drug, called Dato-DXd, could become another blockbuster drug for Astrazeneca.

The Drug Pricing Regulations, which regulate the pricing of essential medicines in India, have long been the focus of numerous legal disputes, many of which have been pending in judicial proceedings for more than a decade.

Over the past seven days, the pharmaceutical sector has experienced significant volatility. Workers in the sector have launched protests, demanding regularization of work, wage increases, more holidays and other related issues.

Purdue Pharma on Thursday received approval from U.S. Bankruptcy Judge Sean Lane for an 18-day extension of the lawsuit against members of its owner, the Sackler family.